Aktualności

Pekin, 18 maja 2021 r.-Lepu Medical Technology (Beijing) Co., Ltd. („ Lepu Medical ”), wiodąca na świecie firma specjalizująca się w opracowywaniu, produkcji i marketingu zaawansowanych technologicznie urządzeń i sprzętu medycznego, 14 maja odbyło się wirtualne „ Seminarium na temat COVID-19 metod wykrywania ”, aby podzielić się teorią i najlepszymi praktykami w celu dalszego promowania globalnej kontroli COVID-19 i zapobiegania jej w Chinach i na całym świecie.

The seminar, which included a virtual training session and a virtual visit to Lepu Medical’s headquarters in Beijing, was part of the seven-day “Seminar on COVID-19 Methods For Detection,” sponsored by China’s Ministry of Commerce and organized by Beijing Holley-Cotect Pharmaceuticals Co., Ltd. The seminar aimed to help other countries and regions to control the pandemic by sharing China’s advanced prevention and control experience. 

Seminarium, które odbyło się praktycznie za pośrednictwem transmisji wideo na żywo, obejmowało sesje pytań i odpowiedzi, dzielenie się seminariami, wizyty w chmurze i inne formaty wirtualne. W sumie 77 uczestników, w tym pracownicy medyczni, pracownicy rządowi i badacze z instytucji naukowo-badawczych z dziewięciu krajów, w tym Kenii, Mauritiusa, Wenezueli, Peru, Ukrainy, Sri Lanki, Iraku, Etiopii i Iranu, dołączyło do wykładu i wizyty w chmurze prowadzonej przez Lepu Medical.

During the seminar, Lepu Medical invited Dr. Jing Yu from the Wuhan Hospital of Traditional Chinese and Western Medicine to deliver a training lecture on basic knowledge and practical experiences of SARS-COV-2 detection, antigen rapid tests, and biochemical indicators for diagnosis. The training course covered the closed loop and seamless SARS-COV-2 detection process from sampling, sample transfer, sample receipt, testing, result reporting and medical waste treatment in various settings including medical institutions, communities, mass screening sites and public places. The seminar, which was well-received by attendees, included a question and answer session in which Dr. Jing Yu and representatives from Lepu Medical answered detailed questions on COVID-19 detection methods, and provided best practice advice to attendees. 

Lepu Medical’s Zestaw do szybkiego testu antygenu 2019-nCoV (koloidalna złota immunochromatografia), a simple screening method for COVID-19 that delivers quick results with high negative predictive value (NPV), was held up as an example by Dr. Yu during the training session. The antigen test method, which is non-invasive, simple to use, cost-efficient, convenient, rapid, stable and accurate has shown high sensitivity of 95.06% and high specificity of 99.62% in clinical trials in IPE Center for Clinical Laboratory, a Lepu Medical subsidiary. Results can be quickly retrieved in 15 minutes. Lepu Medical provides both Lepu Professional Antigen test kits for use by medical institutions and Lepu Antigen self-test kits for individual self-test use, to support diverse testing needs. The Lepu Antigen self-test kit is already approved by BfArM and available in Germany. 

“(For the antigen rapid test,) the positive results can be seen in the early stage after the symptoms (emerged) or in the infection,” said Dr. Yu, addressing participant questions raised about test timing and sensitivity during the lively Q&A session following her lecture, “The sensitivity of the antigen detection depends on the prevalence of the virus. The positive rate of the antigen rapid test is useful in the high prevalent area. If the viral load of the sample is high, the sensitivity of the antigen test and PCR test can be the same.  All biomarkers combined together can be the most effective.”

In addition to the Zestaw do szybkiego testu antygenu 2019-nCoV (koloidalna złota immunochromatografia), Lepu Medical offers other comprehensive diagnostic solutions including nucleic acid series products and solutions, which provide standard tests for COVID-19 diagnosis, and neutralization antibody test products to detect the effectiveness of COVID-19 vaccines in the post-pandemic period. Other COVID-19 products and solutions include sample collection kits, manual sample extraction kits, automated sample extractors, nucleic acid test kits, real-time PCR systems for standard clinical nucleic acid diagnostics, and antibody test kits and systems for vaccine effect evaluation.

Lepu Medical has been providing proactive support to control the COVID-19 pandemic from an early stage. In early 2020, during the outbreak in China, Lepu Medical started emergency production of medical equipment supplies and donated more than RMB5 million of personal protective equipment (PPE), medical devices and cash to severely impacted areas. The company also developed an online free medical consulting system “Doctor Lepu” to assist patients remotely while supporting social distancing. Lepu Medical subsidiaries also dispatched volunteers and a medical aid team to the city of Wuhan and provided mass COVID-19 nucleic acid testing in Beijing where the company is headquartered. Lepu Medical’s products were also widely used across China’s hospitals, medical centers and COVID-19 testing sites. These products included Lepu Medical’s automatic PCR analysis system, personal forehead thermometers, pulse oximeters, monitors, electrocardiographs, household oxygen generators and pharmaceutical products.

Jako globalna firma obejmująca ponad 80 krajów i regionów z ponad 20 globalnymi partnerami OEM, Lepu Medical wykorzystywał swoją globalną sieć i zasoby w zakresie badań i rozwoju, produkcji i dystrybucji, aby wspierać światowe wysiłki na rzecz przeciwdziałania COVID-19. Różne odpowiednie produkty firmy otrzymały certyfikat CE w Europie i zostały zatwierdzone przez Amerykańską Agencję ds. Żywności i Leków (FDA) i rozprowadzone do ponad 140 krajów w celu zwalczania pandemii. Lepu Medical wspiera regularne masowe testy w wielu krajach, pomagając w zorganizowanym ponownym otwarciu szkół w Austrii, dostarczając ponad 20 milionów zestawów testów antygenowych do przeprowadzania ogólnokrajowych testów od stycznia 2021 roku. Zestaw do szybkiego testu antygenu SARS-CoV-2 Lepu, wymieniony na chińskiej białej liście eksportowej, jest certyfikowany przez oficjalny instytut PEI w Niemczech i uzyskał specjalną zgodę Niemieckiego Federalnego Instytutu Leków i Wyrobów Medycznych (BfArM) na samotestowanie.

Upholding the company’s spirit of integrity, quality and scientific innovation, Lepu Medical will continue to focus on combating the COVID-19 pandemic and go above and beyond to provide the best quality of products and services to satisfy the needs of healthcare professionals and patients.